The White House's Office of Management and Budget is officially evaluating a proposal from the Health and Human Services Department that would "lower drug prices and reduce out-of-pocket costs," ahead of President Trump's speech about drug prices next week.

The big picture: HHS and OMB did not respond when asked what was included, but the proposal likely will include ideas from Trump's budget that won't really target the pricing practices of pharmaceutical manufacturers.